drugset / Trial / NCT00388882
Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.
Treatment
Summary
The objective of this study is to evaluate the efficacy and safety of 12 weeks treatment with tiotro pium HandiHaler® 18 mcg daily compared to Combivent® MDI CFC Inhalation Aerosol 2 actuations qid in COPD patients currently prescribed Combivent® MDI.
Timeline
- Start
- 2006-10-04
- Primary completion
- 2007-10-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ipratropium | Small molecule | — | Inhaled |
| Subject | Salbutamol | Unknown | — | Inhaled |
| Subject | Tiotropium | Other / unclassified | 18 ug | Inhaled |